X

Quality Statement

Pacific Biosciences is committed to providing high-quality products that meet customer expectations and comply with regulations. We will achieve these goals by adhering to and maintaining an effective quality-management system designed to ensure product quality, performance, and safety.

X

Image Use Agreement

By downloading, copying, or making any use of the images located on this website (“Site”) you acknowledge that you have read and understand, and agree to, the terms of this Image Usage Agreement, as well as the terms provided on the Legal Notices webpage, which together govern your use of the images as provided below. If you do not agree to such terms, do not download, copy or use the images in any way, unless you have written permission signed by an authorized Pacific Biosciences representative.

Subject to the terms of this Agreement and the terms provided on the Legal Notices webpage (to the extent they do not conflict with the terms of this Agreement), you may use the images on the Site solely for (a) editorial use by press and/or industry analysts, (b) in connection with a normal, peer-reviewed, scientific publication, book or presentation, or the like. You may not alter or modify any image, in whole or in part, for any reason. You may not use any image in a manner that misrepresents the associated Pacific Biosciences product, service or technology or any associated characteristics, data, or properties thereof. You also may not use any image in a manner that denotes some representation or warranty (express, implied or statutory) from Pacific Biosciences of the product, service or technology. The rights granted by this Agreement are personal to you and are not transferable by you to another party.

You, and not Pacific Biosciences, are responsible for your use of the images. You acknowledge and agree that any misuse of the images or breach of this Agreement will cause Pacific Biosciences irreparable harm. Pacific Biosciences is either an owner or licensee of the image, and not an agent for the owner. You agree to give Pacific Biosciences a credit line as follows: "Courtesy of Pacific Biosciences of California, Inc., Menlo Park, CA, USA" and also include any other credits or acknowledgments noted by Pacific Biosciences. You must include any copyright notice originally included with the images on all copies.

IMAGES ARE PROVIDED BY Pacific Biosciences ON AN "AS-IS" BASIS. Pacific Biosciences DISCLAIMS ALL REPRESENTATIONS AND WARRANTIES, EXPRESS, IMPLIED OR STATUTORY, INCLUDING, BUT NOT LIMITED TO, NON-INFRINGEMENT, OWNERSHIP, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL Pacific Biosciences BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER WITH RESPECT TO THE IMAGES.

You agree that Pacific Biosciences may terminate your access to and use of the images located on the PacificBiosciences.com website at any time and without prior notice, if it considers you to have violated any of the terms of this Image Use Agreement. You agree to indemnify, defend and hold harmless Pacific Biosciences, its officers, directors, employees, agents, licensors, suppliers and any third party information providers to the Site from and against all losses, expenses, damages and costs, including reasonable attorneys' fees, resulting from any violation by you of the terms of this Image Use Agreement or Pacific Biosciences' termination of your access to or use of the Site. Termination will not affect Pacific Biosciences' rights or your obligations which accrued before the termination.

I have read and understand, and agree to, the Image Usage Agreement.

I disagree and would like to return to the Pacific Biosciences home page.

Pacific Biosciences
Contact:

Webinar Recap: New Insights in Genome and Transcriptome Research

Monday, May 5, 2014

This week, our CSO Jonas Korlach hosted a webinar entitled “Gain New Insights in Genome and Transcriptome Research with Greater than 10,000 bp Reads.” He spoke to attendees about the PacBio® technology, elements of sequencing, and applications of the ultra-long reads generated by Single Molecule, Real-Time (SMRT®) Sequencing. Here’s a quick recap.

Jonas offered a look at how PacBio’s technology performs in the four key sequencing characteristics that one should consider for any sequencing work: contiguity, accuracy, uniformity, and originality. For contiguity, or how much of a DNA fragment can be sequenced in a single pass, the PacBio platform outperforms all other technologies. Half of data generated in a SMRT Sequencing run is captured in reads longer than 10 kb, and many reads exceed 30 kb. Jonas added that the PacBio RS II also has industry-leading consensus accuracy, routinely at QV50 (>99.999%). Regarding uniformity, or the ability to uniformly sequence all of the DNA present in your sample, the PacBio platform has been shown in an independent study to have the least bias of any sequencing technology. Finally, originality refers to the ability to sequence native, unamplified DNA to avoid amplification bias and allow access to detect epigenetic marks as part of the sequencing, which Jonas noted is a unique attribute of SMRT Sequencing.

Jonas then turned to examples of how scientists are using the PacBio technology for a wide range of applications, starting with high-quality de novo assemblies and finishing of genomes ranging from microbial to large and complex genomes like the human genome. With plant genomes, such as Arabidopsis, SMRT Sequencing assemblies have been shown to include hundreds of thousands of SNPs that were missed by short-read assemblies of the same organism. A scientist working on the spinach genome saw his assembly go from 1.3 million contigs with short-read sequencing to fewer than 10,000 contigs with PacBio. In a human data set we released, the contig N50 of 4.4 Mb represented a 30-fold improvement over the previous best de novo human assembly with a contig N50 of 144 Kb.

The long reads produced by SMRT Sequencing have also been particularly useful for detecting various forms of structural genomic variation, thereby resolving complex or even previously “unsequenceable” genomic regions, and elucidating the complex landscape of alternative splice isoforms in transcriptomes, Jonas noted. Other applications include genome editing, demonstrating SMRT Sequencing as a powerful tool to quantify outcomes of genome-editing experiments, as well as epigenomics since PacBio technology can directly detect base modifications.

Finally, Jonas spoke about upcoming improvements in sample preparation, read length, and data analysis. To see full details, you can view the recorded webinar.

Subscribe for blog updates:

Archives